Moscow [Russia], April 4 (ANI/Sputnik): Russia has registered 8,817 COVID-19 cases in the past 24 hours bringing the cumulative total to 4,580,894, the coronavirus response center said on Sunday.
Bogota [Columbia], April 4 (ANI/Xinhua): Colombia registered 9,149 new COVID-19 cases over the past 24 hours, taking its nationwide tally to 2,437,197, the ministry of health and social protection said on Saturday.
New Delhi [India], April 4 (ANI): Bollywood actor Kartik Aaryan, who had tested positive for coronavirus last month, on Tuesday posted a picture on his social media, waiting in anticipation for his next COVID report.
Islamabad [Pakistan], April 4 (ANI): In the midst of battling a third coronavirus wave, Pakistan recorded over 5,000 fresh COVID-19 infections again in the last 24 hours, after it had breached the mark on Friday.
New Delhi [India], April 4 (ANI): India reported 93,249 new COVID-19 cases and 513 coronavirus-related deaths in the last 24 hours, informed the Union Health Ministry on Sunday.
Brasilia [Brazil], April 4 (ANI/Xinhua): Deaths from COVID-19 in Brazil surpassed 330,000 on Saturday after 1,987 new fatalities registered, bringing the country's death toll to 330,193, the Ministry of Health reported.
Tbilisi [Georgia], April 4, (ANI): Hundreds of people gathered in front of the Parliament of Georgia in Tbilisi on Saturday (local time) to demand the lifting of the overnight curfew that was introduced in November amid a spike in new Covid-19 cases.
Zurich [Switzerland], April 4 (ANI/Sputnik): The Swiss lit hundreds of virtual candles on Saturday to remember more than 9.7 million people who died during the COVID-19 pandemic and send a message of hope to the living.
Ranchi/Jamshedpur (Jharkhand) [India], April 4 (ANI): Jharkhand health minister Banna Gupta has said that the state health department is on alert mode and monitoring the Covid-19 situation very carefully.
Washington [US], April 3 (ANI): Researchers at the University of California San Diego found that the chemical inhibitor K777 reduces the coronavirus' ability to infect cell lines by blocking human enzyme cathepsin L. Clinical trials are underway.